Important update on Complex Rehab Technology

Posted by Reeve Foundation Staff in Daily Dose on June 26, 2017 # Advocacy and Policy

Last week the Centers for Medicare and Medicaid Services (CMS) announced it would NOT be applying Medicare Competitive Bid Program (CBP) information to reduce payment rates for Complex Rehab Technology (CRT) products and supporting services for power wheelchairs. This averts significant cuts that were scheduled to go into effect July 1 and avoids drastic reductions in access to specialized equipment. And it was your advocacy efforts that helped to make it happen!

This is great news for people with disabilities who rely on CRT Group 3 power wheelchairs. CRT products include individually configured manual and power wheelchairs, seating and positioning systems, and other adaptive devices designed to meet a person’s unique medical and functional needs. Access to this specialized equipment is imperative to safeguard quality of life, as well as minimize healthcare costs and maximize independence.

But our work isn’t finished. Unfortunately, there was no change in payment rates for accessories used with CRT manual wheelchairs. We will continue to work with Congress and CMS to protect access to this critical equipment, and update you on actions you can take to make your voice heard.

In the meantime, please check out our active advocacy initiatives, including our fight to protect the Paralysis Resource Center and ongoing discussions around the current healthcare legislations.

Remember, your voice matters and today we are celebrating a step forward to protect the needs and rights of Americans living with disabilities. Together, we achieve more.

The National Paralysis Resource Center website is supported by the Administration for Community Living (ACL), U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $8,700,000 with 100 percent funding by ACL/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by ACL/HHS, or the U.S. Government.